TD:
Nope, I don't follow LFCL. I see them out there on the periphery all the time, but I've never taken a close look. What's an acellular dermal graft, other than something radically different than the approach of ATIS, ORG, et al.? Is it a pharmaceutical, or a dressing? This is important to consider..... what *type* of approval did they get for this first product?
"AlloDerm is a decellularized nonimmunogenic connective tissue graft derived from donated human dermis. Through a patented
process, cells that would cause rejection of the donated tissue are removed and the essential matrix characteristics of the tissue
are preserved, such that the patient's body will accept AlloDerm as its own tissue. When transplanted to a patient, the
AlloDerm dermal matrix is incorporated into the surrounding tissue and is repopulated with the patient's own cells. Moreover,
the AlloDerm matrix guides the new cells to remodel and maintain the matrix, establishing a new functional living tissue."
I'd check to see what sort of approval they got. I have no reason to suspect anything, but there's a company (not LFCL) that conducted a huge trial with a copper compound for wound healing..... the trial failed, but they got an approval for the product as a dressing. That is, they got approval for yet another bandaid. Their original "approval" PR was of just a tad questionable ethics, as it referred to the approval but failed to mention the failed trial.
I am not implying that LFCL is in the dressing business rather than in pharmaceuticals, and I like the business of extending platelet life.
Good luck!
Rick |
